These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33668444)

  • 1. Infant Acute Myeloid Leukemia: A Unique Clinical and Biological Entity.
    Calvo C; Fenneteau O; Leverger G; Petit A; Baruchel A; Méchinaud F
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33668444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
    Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological characteristics of extramedullary acute megakaryoblastic leukemia (AMKL): report of a case with initial mastoid presentation and review of literature to compare extramedullary AMKL and non-AMKL cases.
    Liang C; Chan KH; Yoon PJ; Lovell MA
    Pediatr Dev Pathol; 2012; 15(5):385-92. PubMed ID: 22667334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial.
    Schweitzer J; Zimmermann M; Rasche M; von Neuhoff C; Creutzig U; Dworzak M; Reinhardt D; Klusmann JH
    Ann Hematol; 2015 Aug; 94(8):1327-36. PubMed ID: 25913479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive mutational profiling of core binding factor acute myeloid leukemia.
    Duployez N; Marceau-Renaut A; Boissel N; Petit A; Bucci M; Geffroy S; Lapillonne H; Renneville A; Ragu C; Figeac M; Celli-Lebras K; Lacombe C; Micol JB; Abdel-Wahab O; Cornillet P; Ifrah N; Dombret H; Leverger G; Jourdan E; Preudhomme C
    Blood; 2016 May; 127(20):2451-9. PubMed ID: 26980726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy.
    Roussy M; Bilodeau M; Jouan L; Tibout P; Laramée L; Lemyre E; Léveillé F; Tihy F; Cardin S; Sauvageau C; Couture F; Louis I; Choblet A; Patey N; Gendron P; Duval M; Teira P; Hébert J; Wilhelm BT; Choi JK; Gruber TA; Bittencourt H; Cellot S
    Genes Chromosomes Cancer; 2018 Jun; 57(6):311-319. PubMed ID: 29427526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C; Creutzig U; Reinhardt D
    Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
    Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
    Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trial.
    Teyssier AC; Lapillonne H; Pasquet M; Ballerini P; Baruchel A; Ducassou S; Fenneteau O; Petit A; Cuccuini W; Ragu C; Preudhomme C; Mercher T; Sirvent N; Leverger G
    Pediatr Hematol Oncol; 2017 Nov; 34(8):425-427. PubMed ID: 29303660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity.
    Masetti R; Bertuccio SN; Pession A; Locatelli F
    Br J Haematol; 2019 Feb; 184(3):337-347. PubMed ID: 30592296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia.
    Wiggers CRM; Govers AMAP; Lelieveld D; Egan DA; Zwaan CM; Sonneveld E; Coffer PJ; Bartels M
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27785. PubMed ID: 31044544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of homeobox gene HOXA9 in childhood acute leukemia, and its clinical significance].
    Jia XH; Zhu LP; Li JC; Wang CC
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):268-72. PubMed ID: 23607948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique clinical and biological features of leukemia in Down syndrome children.
    Xavier AC; Ge Y; Taub J
    Expert Rev Hematol; 2010 Apr; 3(2):175-86. PubMed ID: 21083461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis].
    Zhao CX; Wang JM; Li JM; Zou SH; Chen FY; Liang AB; Hou J; Hu XX; Zhang YX; Gu SY; Zhu JY; Li P; Du J; Yang YN; Qin YW; Wang XR; Wang C
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3145-3151. PubMed ID: 31694105
    [No Abstract]   [Full Text] [Related]  

  • 15. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes.
    de Rooij JD; Branstetter C; Ma J; Li Y; Walsh MP; Cheng J; Obulkasim A; Dang J; Easton J; Verboon LJ; Mulder HL; Zimmermann M; Koss C; Gupta P; Edmonson M; Rusch M; Lim JY; Reinhardt K; Pigazzi M; Song G; Yeoh AE; Shih LY; Liang DC; Halene S; Krause DS; Zhang J; Downing JR; Locatelli F; Reinhardt D; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M; Gruber TA
    Nat Genet; 2017 Mar; 49(3):451-456. PubMed ID: 28112737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MN1-Fli1 oncofusion transforms murine hematopoietic progenitor cells into acute megakaryoblastic leukemia cells.
    Wenge DV; Felipe-Fumero E; Angenendt L; Schliemann C; Schmidt E; Schmidt LH; Thiede C; Ehninger G; Berdel WE; Arteaga MF; Mikesch JH
    Oncogenesis; 2015 Dec; 4(12):e179. PubMed ID: 26690545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.
    Masetti R; Bertuccio SN; Astolfi A; Chiarini F; Lonetti A; Indio V; De Luca M; Bandini J; Serravalle S; Franzoni M; Pigazzi M; Martelli AM; Basso G; Locatelli F; Pession A
    J Hematol Oncol; 2017 Jan; 10(1):26. PubMed ID: 28109323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: a Pediatric Oncology Group Study.
    Carroll A; Civin C; Schneider N; Dahl G; Pappo A; Bowman P; Emami A; Gross S; Alvarado C; Phillips C
    Blood; 1991 Aug; 78(3):748-52. PubMed ID: 1859887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ploidy and clinical characteristics of childhood acute myeloid leukemia: A NOPHO-AML study.
    Sandahl JD; Kjeldsen E; Abrahamsson J; Ha SY; Heldrup J; Jahnukainen K; Jónsson OG; Lausen B; Palle J; Zeller B; Forestier E; Hasle H
    Genes Chromosomes Cancer; 2014 Aug; 53(8):667-75. PubMed ID: 24753324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.